Boiron (Boiron) 3-Year Revenue Growth Rate : -1.10% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Boiron 3-Year Revenue Growth Rate?

Boiron's Revenue per Share for the six months ended in Dec. 2023 was $15.91.

During the past 12 months, Boiron's average Revenue per Share Growth Rate was -7.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -1.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -3.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Boiron was 10.30% per year. The lowest was -8.50% per year. And the median was 3.20% per year.

Competitive Comparison of Boiron's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boiron's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Boiron's 3-Year Revenue Growth Rate falls into.

Boiron 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Boiron (OTCPK:BOIRF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Boiron 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Boiron's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Boiron (Boiron) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (OTCPK:BOIRF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BOI:France BON:Germany

Address

2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510

Website

http://www.boiron.com

Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Boiron (Boiron) Headlines

From GuruFocus

The Fastest Share Repurchasing Companies in Europe

By Holly LaFon Holly LaFon • 07-04-2014